Evidence map›Paper›PMID 20003097›Full record

ArticleActa physiologica (Oxford, England)2010

Role of ataxia telangiectasia mutated in insulin signalling of muscle-derived cell lines and mouse soleus.

I Jeong, A Y Patel, Z Zhang, P B Patil, S T Nadella, S Nair, L Ralston, J K Hoormann, J S Fisher

Open access · greenAbstract read
In one paragraph

Article in Acta physiologica (Oxford, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Stem cell models in ataxia-telangiectasia.Neural regeneration research · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Impaired insulin-stimulated glucose transport in ATM-deficient mouse skeletal muscle.Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme · 2013
    Article
  6. Article
  7. Article
  8. Ataxia telangiectasia mutated influences cytochrome c oxidase activity.Biochemical and biophysical research communications · 2011
    Article
  9. A role for AMPK in increased insulin action after serum starvation.American journal of physiology. Cell physiology · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

I JeongDepartment of Biology, Saint Louis University, MO 63103, USA.
A Y Patel
Z Zhang
P B Patil
S T Nadella
S Nair
L Ralston
J K Hoormann
J S Fisher
Saint Louis University · USMonsanto (United States) · USSigma Research (United States) · US

Funding

National Center for Muscle Rehabilitation ResearchR24HD050837 · NICHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LIEBER, RICHARD L., WARD, SAMUEL RICHARD · 2005 to 2014
$7.2M
ARK5 AMP-activated protein kinase and glucose transportK01DK066330 · NIDDK · SAINT LOUIS UNIVERSITY · PI FISHER, JONATHAN S · 2004 to 2007
$373k
The role of ATM in glucose transport and insulin signaling in skeletal muscleR15DK080437 · NIDDK · SAINT LOUIS UNIVERSITY · PI FISHER, JONATHAN S. · 2008 to 2010
$359k
NICHD NIH HHS R24 HD050837NICHD NIH HHS R24HD050837NIDDK NIH HHS K01 DK066330NIDDK NIH HHS R15 DK080437
6 · The paper itself

Abstract

aimAtaxia telangiectasia mutated (ATM) reportedly plays a role in insulin-stimulated activation of Akt in some cell types but not in others. The role of ATM in insulin signalling has not been firmly resolved for skeletal muscle cells, for which Akt phosphorylation is a pivotal step in stimulation of glucose transport. Accordingly, our aim was to determine the role of ATM in insulin effects for cell lines derived from skeletal muscle and for skeletal muscle.

methodsWe examined insulin effects in L6 myotubes, mouse soleus, C2C12 myotubes and differentiated rhabdomyosarcoma (RD) cells in the presence and absence of a low concentration (1 microm) of the ATM inhibitor KU55933. We also compared insulin signalling in C2C12 cells expressing shRNA against ATM and control cell lines (empty vector; cells expressing non-targeting shRNA).

resultsIn L6 myotubes and mouse soleus muscle, KU55933 inhibited insulin-stimulated phosphorylation of the 160 kDa substrate of Akt (AS160) despite no effect on Akt. In contrast, KU55933 prevented insulin-stimulated Akt phosphorylation in C2C12 myotubes. Furthermore, C2C12 myotubes expressing shRNA against ATM displayed reduced insulin-stimulated Akt phosphorylation compared to controls. KU55933 also decreased insulin-stimulated Akt phosphorylation in differentiated RD cells.

conclusionThese model-dependent differences in the role of ATM in insulin action demonstrate a role of ATM in insulin-stimulated phosphorylation of Akt (in C2C12 and RD cells) but also allow the elucidation of a novel, Akt-independent role of ATM (in L6 myotubes and mouse soleus, at the level of AS160) in insulin signalling.

Indexed as

AnimalsAtaxia TelangiectasiaBiological TransportGlucoseGlucose Transporter Type 4InsulinMiceMuscle CellsMuscle ContractionMuscle Fibers, SkeletalMuscle, SkeletalMutationPhosphorylationProto-Oncogene Proteins c-aktSignal TransductionGlucoseGlucose Transporter Type 4InsulinProto-Oncogene Proteins c-akt

Identifiers

PMID20003097
PMCPMC2875195
OpenAlexW2055420536

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.